Elisa Callegari

1PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 19, 2026
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.

Silvia Sabbioni, Paola Guerriero, Ram C Shankaraiah

Pageof 1